Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-19T22:21:42.073Z Has data issue: false hasContentIssue false

Implementation and evaluation of a measles/rubella vaccination campaign in a campus university in the UK following an outbreak of rubella

Published online by Cambridge University Press:  01 August 1998

J. STEVENSON
Affiliation:
Argyll and Clyde Health Board
G. MURDOCH
Affiliation:
Airthrey Park Medical Centre, University of Stirling
A. RILEY
Affiliation:
Forth Valley Health Board
B. DUNCAN
Affiliation:
Forth Valley Health Board
M. McWHIRTER
Affiliation:
Forth Valley Health Board
P. CHRISTIE
Affiliation:
Scottish Centre for Infection and Environmental Health
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

An age shift in rubella infection to young adults has occurred in Scotland since the introduction of a first dose measles, mumps and rubella (MMR) vaccination in 1988 and a second dose measles/rubella (MR) vaccination in 1994/95. The Health Board was alerted to an outbreak of rubella at Stirling University by the notification of 6 cases amongst male students aged 18–28 years with dates of onset between 3 March and 21 March 1996. In response, a MR vaccination campaign was conducted to enhance population immunity to rubella within the university population and to reduce the likelihood of further cases. A total of 1795 students, staff and visitors were vaccinated. Vaccine coverage of 46% was estimated to be sufficient to boost rubella immunity in full time male students in university accommodation to 88·7–91·0%, just above the upper critical level of herd immunity for rubella of 85–88%. Students in colleges and universities in the UK will remain at increased risk of outbreaks of rubella and measles until the cohort who have received a two dose schedule of MR form the bulk of the college population. It may be prudent for tertiary education colleges and other institutions in the UK with young adults living in shared residential accommodation to offer MR vaccination to new entrants, targeting those who have not previously received the vaccine, between now and the year 2000.

Type
Research Article
Copyright
© 1998 Cambridge University Press